NCT00202280View on ClinicalTrials.gov

Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

September 30, 2006

Study Completion Date

June 30, 2009

Conditions

First Episode Psychosis

Interventions

DRUG

Folic Acid 5mg, Vitamin B12 0.4mg and B6 50mg

Trial Locations (1)

3052

ORYGEN Youth Health, Melbourne

Sponsors

Lead Sponsor

Melbourne Health

All Listed Sponsors

collaborator

Stanley Medical Research Institute

OTHER

lead

Melbourne Health

OTHER